Literature DB >> 1833312

The functional activity of high endothelial venules: a role for the subcapsular sinus macrophages in the lymph node.

R E Mebius1, J Bauer, A J Twisk, J Brevé, G Kraal.   

Abstract

Adherence of lymphocytes to high endothelial venules (HEV3) is the first step in normal lymphocyte emigration and recirculation. At sites of chronic inflammation, venules often become high-walled and may also be a site for leukocytes to leave the bloodstream. The immunologic and inflammatory mediators, responsible for these effects on endothelial cells, may be important for the maintenance and function of HEV in physiological conditions. It is reported here that the morphological and functional aspects of HEV can be studied by organ cultures of lymph nodes (LN). At 24 h of culture, the appearance of the node was still quite normal, whereas the HEV became flat-walled, with a 45-50% reduction in the capacity to bind lymphocytes. This decrease in function of HEV could be reduced when LN were cultured in the presence of lipopolysaccharides (LPS). The effect of LPS on the function of HEV was presumably mediated by macrophages in the subcapsular sinus, because HEV in LN, which were depleted of subcapsular sinus and medullary macrophages previous to culture, could not be stimulated by addition of LPS to the cultures.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833312     DOI: 10.1016/s0171-2985(11)80663-7

Source DB:  PubMed          Journal:  Immunobiology        ISSN: 0171-2985            Impact factor:   3.144


  8 in total

1.  Molecular characterization of NF-HEV, a nuclear factor preferentially expressed in human high endothelial venules.

Authors:  Espen S Baekkevold; Myriam Roussigné; Takeshi Yamanaka; Finn-Eirik Johansen; Frode L Jahnsen; François Amalric; Per Brandtzaeg; Monique Erard; Guttorm Haraldsen; Jean-Philippe Girard
Journal:  Am J Pathol       Date:  2003-07       Impact factor: 4.307

2.  Heterogeneity of endothelial cells: the specialized phenotype of human high endothelial venules characterized by suppression subtractive hybridization.

Authors:  J P Girard; E S Baekkevold; T Yamanaka; G Haraldsen; P Brandtzaeg; F Amalric
Journal:  Am J Pathol       Date:  1999-12       Impact factor: 4.307

Review 3.  Lymphatic function and immune regulation in health and disease.

Authors:  Shan Liao; Timothy P Padera
Journal:  Lymphat Res Biol       Date:  2013-09-11       Impact factor: 2.589

4.  Splenic adherent cells, stimulated in vitro, induce the reactive formation of lymphoid follicles and germinal centres in draining lymph nodes after subcutaneous transfusion into syngeneic mice.

Authors:  K Tanaka; D Chen; S Negishi; S Aizawa; H Hoshi
Journal:  J Anat       Date:  1998-07       Impact factor: 2.610

5.  Transgenic LacZ under control of Hec-6st regulatory sequences recapitulates endogenous gene expression on high endothelial venules.

Authors:  Shan Liao; Kevin Bentley; Marielle Lebrun; Werner Lesslauer; Frank H Ruddle; Nancy H Ruddle
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-05       Impact factor: 11.205

6.  Central Role of CD169+ Lymph Node Resident Macrophages in the Adjuvanticity of the QS-21 Component of AS01.

Authors:  Sophie Detienne; Iain Welsby; Catherine Collignon; Sandrine Wouters; Margherita Coccia; Sophie Delhaye; Laurye Van Maele; Séverine Thomas; Maëlle Swertvaegher; Aurélie Detavernier; Abdelatif Elouahabi; Stanislas Goriely; Arnaud M Didierlaurent
Journal:  Sci Rep       Date:  2016-12-20       Impact factor: 4.379

7.  Macrophage depletion by free bisphosphonates and zoledronate-loaded red blood cells.

Authors:  Raffaella Sabatino; Antonella Antonelli; Serafina Battistelli; Reto Schwendener; Mauro Magnani; Luigia Rossi
Journal:  PLoS One       Date:  2014-06-26       Impact factor: 3.240

8.  Tertiary lymphoid structures are confined to patients presenting with unifocal Langerhans Cell Histiocytosis.

Authors:  Willemijn T Quispel; Eline C Steenwijk; Vincent van Unen; Susy J Santos; Lianne Koens; Reina Mebius; R Maarten Egeler; Astrid G S van Halteren
Journal:  Oncoimmunology       Date:  2016-03-28       Impact factor: 8.110

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.